Skip to content
Roopa Industries logo

Roopa Industries

530991 BSE
₹42.09

Close ·

P/E
263.06
View as Markdown
MCP
Close 4 Nov 2026 ₹42.09 −8.80 −17.3% 1Y
Start ₹50.89

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare

Price-based figures at the close · EPS basis: Standalone · TTM

ROCE
15.00%
Debt to Equity
1.72
EPS (TTM)
₹0.16
Book Value
₹22.37
Market Cap
—
P/E (TTM)
263.06
P/B
1.88
ROE
23.80%
Dividend Yield
0.00%
EBITDA
₹8.30 Cr
52W High
₹63.40
52W Low
₹38.10

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

46 Average

Data confidence 100/100

Category scores

Quality
70
Strong
Returns, margins, earnings quality 22% weight
Valuation
36
Poor
Cheap vs sector & own history 24% weight
Growth
43
Weak
Sales & profit trajectory 9% weight
Financial Health
23
Poor
Solvency, leverage, coverage 9% weight
Momentum
28
Poor
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

No strengths listed

Weaknesses

2
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Debtor days have increased from 48.4 to 62.8 days.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1261
OscillatorsBearish261
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
41.88
Neutral
MACD (12,26,9)
−1.18
Bearish
SMA (50)
46.10
Bearish
SMA (200)
48.01
Bearish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+15.24%
5Y+34.57%
3Y+18.98%
1Y+5.79%
TTM+3.71%

Net profit

Net profit growth by window
10YZero base
5Y−100.00%
3Y−100.00%
1Y−100.00%
TTM−93.63%

Operating cash flow

Operating cash flow growth by window
10Y+17.46%
5YTurned positive
3YZero base
1YTurned positive
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+9.48 pp
5Y−4.09 pp
3Y+0.99 pp
1Y+2.94 pp
TTM+2.91 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹30.00 Cr
Mar 2018₹19.00 Cr
Mar 2019₹30.00 Cr
Mar 2020₹28.00 Cr
Mar 2021₹29.00 Cr
Mar 2022₹51.00 Cr
Mar 2023₹76.00 Cr
Mar 2024₹70.00 Cr
Mar 2025₹121 Cr
Mar 2026₹128 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹0.00 Cr
Mar 2018₹1.00 Cr
Mar 2019₹1.00 Cr
Mar 2020₹0.00 Cr
Mar 2021₹1.00 Cr
Mar 2022₹1.00 Cr
Mar 2023₹1.00 Cr
Mar 2024₹2.00 Cr
Mar 2025₹2.00 Cr
Mar 2026₹0.00 Cr

Quarterly Results

₹ Cr
530991 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
14.95
14.15
19.24
22.08
34.51
25.61
30.73
29.83
35.07
28.74
33.54
30.14
33.32
Expenses
13.92
12.45
18.36
21.15
33.46
23.97
29.76
29.39
33.67
27.11
31.5
27.07
31.79
Operating Profit
1.03
1.7
0.88
0.93
1.05
1.64
0.97
0.44
1.4
1.63
2.04
3.07
1.53
OPM %
6.89%
12.01%
4.57%
4.21%
3.04%
6.4%
3.16%
1.48%
3.99%
5.67%
6.08%
10.19%
4.59%
Other Income
0
0.02
0.4
0.71
0.24
0
0.92
1.14
0.02
0
0
−3.98
0.02
Interest
0.56
0.69
0.7
0.68
0.79
0.71
0.67
0.66
0.86
0.83
0.79
0.74
0.93
Depreciation
0.23
0.23
0.23
0.19
0.2
0.2
0.26
0.19
0.2
0.19
0.19
0.21
0.19
PBT
0.24
0.8
0.35
0.77
0.3
0.73
0.96
0.73
0.36
0.61
1.06
−1.86
0.43
Tax %
20.83%
25%
25.71%
38.96%
10%
19.18%
20.83%
43.84%
25%
24.59%
26.42%
−23.12%
23.26%
Net Profit
0.19
0.6
0.27
0.46
0.27
0.58
0.76
0.42
0.28
0.46
0.77
−1.43
0.33
EPS (₹)
0.24
0.76
0.34
0.58
0.34
0.74
0.97
0.53
0.36
0.58
0.98
−1.82
0.42

Profit & Loss

₹ Cr
530991 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
31
31
30
19
30
28
29
51
76
70
121
128
126
Expenses
29
31
28
22
28
26
26
48
72
66
117
119
117
Operating Profit
2
−1
2
−3
2
2
3
3
4
4
4
8
8
OPM %
7%
−2.8%
7%
−14%
8%
7%
10%
7%
5%
6%
3.4%
6%
7%
Other Income
0
3
0
5
0
1
0
0
1
1
2
−4
−4
Interest
1
1
2
1
1
1
1
1
2
3
3
3
3
Depreciation
1
1
1
1
1
1
1
1
1
1
1
1
1
PBT
0
0
0
0
1
1
1
1
2
2
3
0
0
Tax %
11%
35%
56%
−22%
24%
54%
24%
26%
25%
30%
25%
56%
—
Net Profit
0
0
0
1
1
0
1
1
1
2
2
0
0
EPS (₹)
0.2
0.22
0.24
0.69
0.76
0.47
0.92
1.3
1.72
1.93
2.58
0.1
0.16
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
530991 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
8
8
8
8
8
8
8
8
8
8
8
8
Reserves
1
1
2
2
3
3
4
5
6
8
10
10
Borrowings
8
8
11
16
15
14
13
12
19
26
33
31
Other Liabilities
8
8
8
10
11
14
21
24
24
23
26
23
Total Liabilities
26
25
29
35
36
38
46
49
57
65
76
72
Fixed Assets
8
7
7
6
6
11
10
10
10
9
8
8
CWIP
0
0
0
2
4
0
0
1
1
1
1
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
18
18
22
27
26
28
36
39
46
55
68
64
Total Assets
26
25
29
35
36
38
46
49
57
65
76
72

Cash Flow

₹ Cr
530991 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
1
1
−1
−5
4
2
−1
2
0
2
−7
5
Investing
0
0
0
2
−2
1
1
4
−1
1
2
0
Financing
0
−1
2
2
−2
−3
−1
−5
2
−2
5
−8
Net Cash Flow
0
0
0
0
0
0
0
1
0
1
0
−3
Free Cash Flow
0
1
−2
−7
2
2
−1
2
−2
2
−7
4
CFO/OP
28
−146
−50
168
184
157
−11
78
2
60
−143
59

Ratios

530991 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
66
99
146
233
134
157
147
112
34
43
39
63
Inventory Days
143
70
139
217
171
256
409
140
109
168
121
102
Days Payable
132
100
122
177
123
219
280
86
42
96
56
41
Cash Conversion Cycle
77
69
164
273
182
194
277
166
101
116
104
123
Working Capital Days
32
69
114
214
108
104
114
37
1
10
36
32
ROCE %
10%
10%
10%
6%
9%
9%
8%
10%
13%
12%
12%
15%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Roopa Industries insights

63 extracted metrics across FY10–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 48.03%
  • Public 40.96%
  • Others 10.75%
  • FIIs 0.25%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Roopa Industries

What does Roopa Industries Ltd do?
Incorporated in 1985, Roopa Industries Ltd is in the business of TPP and its allied products
Where is Roopa Industries Ltd (ROOPAIND) listed?
Roopa Industries Ltd trades under code 530991 on the BSE.
Which sector does Roopa Industries Ltd belong to?
Roopa Industries Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the PE ratio of Roopa Industries Ltd?
Roopa Industries Ltd trades at a PE ratio of 263.06 as of 4 Nov 2026, on earnings per share of ₹0.16, against a book value of ₹22.37 per share.
What is the 52-week high and low of Roopa Industries Ltd?
Over the last 52 weeks Roopa Industries Ltd has traded between ₹38.1 and ₹63.4 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Roopa Industries Ltd?
Roopa Industries Ltd reported a return on equity of 23.80%. Its debt-to-equity ratio is 1.72.

Company Information

Incorporated in 1985, Roopa Industries Ltd is in the business of TPP and its allied products

Website roopaindustries.com
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/530991.md for Roopa Industries Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month